How long can you take tirzepatide for weight loss?

The myth: tirzepatide is a short course, like a course of antibiotics

The most common misconception about tirzepatide for weight loss is that it works like a finite prescription — you take it for a few months, reach a target weight, then stop. The reality is more nuanced, and understanding it matters before you start.

Obesity is a chronic condition with biological drivers that do not disappear once weight comes off. The hunger signals, metabolic adaptations and hormonal changes that made weight hard to lose in the first place tend to reassert themselves when treatment stops. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average weight reductions of around 20–21% at the 15mg dose over 72 weeks — but follow-up data from extension studies consistently found that a large proportion of that weight returned within a year of stopping. That is not a failure of the medicine; it reflects the biology of the condition it treats.

Tirzepatide works by activating two gut-hormone receptors involved in appetite regulation and blood-sugar control. When treatment ends, those pathways return to baseline. So the question of how long tirzepatide treatment lasts is really a question about managing a long-term condition, not completing a course.

What UK guidance actually says about duration

The UK licence for tirzepatide, sold as Mounjaro, does not impose a time limit. It is licensed for ongoing weight management alongside a reduced-calorie diet and increased physical activity in adults meeting the BMI criteria. There is no SmPC clause that reads "stop after X months".

NICE's appraisal of tirzepatide, TA1026, does include one meaningful review trigger: if a patient has not lost at least 5% of their starting body weight after six months at the highest tolerated dose, the prescriber should review whether continuing is appropriate. That is a response-based checkpoint, not a blanket time limit. Compare this with NICE's separate recommendation for semaglutide (Wegovy injection), which specifies a maximum treatment duration of two years within an NHS specialist weight management service. No equivalent duration cap appears in TA1026 for tirzepatide.

In practice, weight loss on tirzepatide tends to accelerate in the first six to twelve months and then plateau, which is normal and expected. The plateau is not a signal to stop; it is often the point at which maintenance becomes the goal.

How long do you actually take tirzepatide for weight loss to get results?

Most people taking tirzepatide find that meaningful weight reduction builds over several months rather than arriving quickly. The early weeks at the 2.5mg starter dose are primarily about letting your system adjust; the prescriber titrates upward from there, typically in four-week steps. If you are wondering how long it takes to lose weight on tirzepatide, the short version is that most of the clinical-trial results were measured at 72 weeks, just over a year and a half, and our guide to how long tirzepatide takes to produce weight loss walks through what to expect at each stage of that journey.

That timeline is relevant when you are thinking about how long you will need to continue treatment. Stopping at three months, before reaching a meaningful maintenance dose, will not give you the same picture as continuing through a full titration. If you are thinking about a shorter trial before committing, it is worth discussing realistic expectations with a prescriber first.

For people who want to understand how soon tirzepatide starts working, the appetite-reduction effect often becomes noticeable within the first few weeks, even at lower doses, but significant weight change accumulates over months.

Stopping treatment: what happens and when is it the right call?

Some people do stop tirzepatide, because they have met their health goals and their prescriber agrees ongoing treatment is no longer the priority, or because they experience side effects that do not resolve, or for personal reasons. That is a legitimate outcome. The decision should involve your prescriber, not be made between prescription refills.

If weight regain after stopping concerns you, it is worth exploring that conversation early. Some people transition to a lower maintenance dose rather than stopping abruptly; others focus on the lifestyle changes that tirzepatide makes easier to embed. The full picture of how Mounjaro works over time helps set realistic expectations about what stopping means.

There are no hidden exit penalties at nume. When a plain box arrives via DPD and you open it, the pen inside is yours to use as prescribed, and any future order simply goes through the same clinical review again. If you decide to pause, no one chases you. If you want to restart, a prescriber reviews your situation fresh.

The NHS provides context on tirzepatide, including what to discuss with your healthcare team before making any changes. If you have questions about your specific circumstances, speaking to our prescribers is the natural next step.